| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |